GOPGNH60-DMMA | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

441 results for “GOPGNH60-DMMA”

Trials

View all 368 →

MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study)

40 participants · First posted Mar 24, 2023

Comparative Acute Effects of R-MDMA and S-MDMA in Healthy Participants

26 participants · First posted Apr 1, 2025

MDMA-assisted Therapy for Fibromyalgia

20 participants · First posted Oct 4, 2023

Drugs

iNTS-GMMA

MDMA + citalopram

dmPA-7909

Organizations

EMMA WELLS

Australia

Emma Pendleton Bradley Hospital

United States

Doma Biopharmaceutical (Suzhou) Co., Ltd.

China

News

View all 64 →

pH-Responsive Graphene Nanomaterials Achieve Enhanced Tumor Targeting in Breakthrough Cancer Drug Delivery Study

Quantum Dots in Biomedicine: From Precision Imaging to Single-Virus Tracking and the Road to Clinical Translation

Optimizing Neoadjuvant Immunotherapy Strategies in Colorectal Cancer

Page 1 of 45